To investigate the sensitivity, specificity, and validity of the tau PET tracer [18F] PI-2620 for measuring toxic tau accumulation in the brain based on how the intensity and anatomical distribution of its uptake differs between cognitively normal adults, amyloid-positive individuals with suspected non-amnestic Alzheimers disease (naAD), and amyloid-negative individuals with …